KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 122 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 4.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,016 | -44.6% | 19,415 | +40.7% | 0.00% | – |
| Q4 2022 | $46,920 | -72.9% | 13,800 | -56.5% | 0.00% | – |
| Q3 2022 | $173,000 | -25.4% | 31,700 | -38.4% | 0.00% | – |
| Q2 2022 | $232,000 | -55.1% | 51,500 | -41.8% | 0.00% | -100.0% |
| Q1 2019 | $517,000 | -25.0% | 88,530 | +20.4% | 0.00% | 0.0% |
| Q4 2018 | $689,000 | +83.7% | 73,530 | +233.9% | 0.00% | 0.0% |
| Q3 2018 | $375,000 | -1.8% | 22,020 | -2.1% | 0.00% | 0.0% |
| Q2 2018 | $382,000 | -58.6% | 22,500 | -67.3% | 0.00% | 0.0% |
| Q1 2018 | $923,000 | +401.6% | 68,736 | +259.3% | 0.00% | – |
| Q4 2017 | $184,000 | – | 19,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
| TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
| Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
| Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
| Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
| Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
| SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
| Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |